These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 11994179
21. Antiepileptic hypersensitivity syndrome in children. Bessmertny O, Hatton RC, Gonzalez-Peralta RP. Ann Pharmacother; 2001 May; 35(5):533-8. PubMed ID: 11346057 [Abstract] [Full Text] [Related]
22. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Knowles SR, Shapiro LE, Shear NH. Drug Saf; 1999 Dec; 21(6):489-501. PubMed ID: 10612272 [Abstract] [Full Text] [Related]
23. Anticonvulsant hypersensitivity syndrome: clinic case and literature review. Leonangeli S, Fraire JA, Loza JL. Rev Fac Cien Med Univ Nac Cordoba; 2020 Aug 21; 77(3):211-213. PubMed ID: 32991111 [Abstract] [Full Text] [Related]
26. Anticonvulsant hypersensitivity: an unfortunate case of triple exposure to phenytoin. Brown CE, Smith GD, Coniglione T. J Fam Pract; 1997 Nov 21; 45(5):434-7. PubMed ID: 9374970 [Abstract] [Full Text] [Related]
27. Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndrome. Petkov T, Pehlivanov G, Grozdev I, Kavaklieva S, Tsankov N. Eur J Dermatol; 2007 Nov 21; 17(5):422-7. PubMed ID: 17673387 [Abstract] [Full Text] [Related]
28. Antiepileptic hypersensitivity and DRESS syndrome due to phenytoin in two pediatric cases. Armin S, Chavoshzadeh Z, Mohkam M, Rezaei N. Turk J Pediatr; 2009 Nov 21; 51(1):76-7. PubMed ID: 19378897 [Abstract] [Full Text] [Related]
29. Carbamazepine-induced pseudolymphoma with CD-30 positive cells. Nathan DL, Belsito DV. J Am Acad Dermatol; 1998 May 21; 38(5 Pt 2):806-9. PubMed ID: 9591791 [Abstract] [Full Text] [Related]
30. Anticonvulsant cross-sensitivity. Canaday BR. Am J Health Syst Pharm; 1997 Nov 15; 54(22):2616-7. PubMed ID: 9397227 [No Abstract] [Full Text] [Related]
31. The DRESS syndrome: the great clinical mimicker. Fleming P, Marik PE. Pharmacotherapy; 2011 Mar 15; 31(3):332. PubMed ID: 21361742 [Abstract] [Full Text] [Related]
32. Anticonvulsant hypersensitivity syndrome with marked eosinophilia in treatment of diabetic neuropathy. Yamada N, Kaneko K, Saito Y, Tatsuno I. Diabetes Care; 2002 Jun 15; 25(6):1099-100. PubMed ID: 12032126 [No Abstract] [Full Text] [Related]
35. Eosinophilic esophagitis is a component of the anticonvulsant hypersensitivity syndrome: description of two cases. Balatsinou C, Milano A, Caldarella MP, Laterza F, Pierdomenico SD, Cuccurullo F, Neri M. Dig Liver Dis; 2008 Feb 15; 40(2):145-8. PubMed ID: 17395557 [Abstract] [Full Text] [Related]
37. Anticonvulsant hypersensitivity syndrome leading to reversible myocarditis. Zaidi AN. Can J Clin Pharmacol; 2005 Feb 15; 12(1):e33-40. PubMed ID: 15725647 [Abstract] [Full Text] [Related]
38. Pathogenesis and clinical approaches to anticonvulsant hypersensitivity syndrome: current state of knowledge. Scaparrotta A, Verrotti A, Consilvio NP, Cingolani A, Di Pillo S, Di Gioacchino M, Verini M, Chiarelli F. Int J Immunopathol Pharmacol; 2011 Feb 15; 24(2):277-84. PubMed ID: 21658302 [Abstract] [Full Text] [Related]
40. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Tennis P, Stern RS. Neurology; 1997 Aug 15; 49(2):542-6. PubMed ID: 9270593 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]